{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:09:59Z","timestamp":1789877399327,"version":"4.0.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,10,19]],"date-time":"2014-10-19T00:00:00Z","timestamp":1413676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00428-014-1672-9","type":"journal-article","created":{"date-parts":[[2014,10,18]],"date-time":"2014-10-18T03:52:51Z","timestamp":1413604371000},"page":"687-695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Increased angiogenesis and FGFR protein expression indicate a favourable prognosis in bladder cancer"],"prefix":"10.1007","volume":"465","author":[{"given":"Simone","family":"Bertz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Abe\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Schwarz-Furlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Alfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinand","family":"Hofst\u00e4dter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Stoehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas KA","family":"Gaumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,19]]},"reference":[{"key":"1672_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/08977190500096004","volume":"23","author":"M Antoine","year":"2005","unstructured":"Antoine M, Wirz W, Tag CG, Mavituna M, Emans N, Korff T, Stoldt V, Gressner AM, Kiefer P (2005) Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells. Growth Factors 23:87\u201395","journal-title":"Growth Factors"},{"key":"1672_CR2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc1093","volume":"3","author":"G Bergers","year":"2003","unstructured":"Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3:401\u2013410. doi: 10.1038\/nrc1093","journal-title":"Nat. Rev. Cancer"},{"key":"1672_CR3","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0002-9440(10)64665-2","volume":"158","author":"C Billerey","year":"2001","unstructured":"Billerey C, Chopin D, Aubriot-Lorton MH, Ricol D, Diez G, de Medina S, Van Rhijn B, Bralet MP, Lefrere-Belda MA, Lahaye JB, Abbou CC, Bonaventure J, Zafrani ES, van der Kwast T, Thiery JP, Radvanyi F (2001) Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors. Am J Pathol 158:1955\u20131959","journal-title":"Am J Pathol"},{"key":"1672_CR4","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/jnci\/87.21.1603","volume":"87","author":"BH Bochner","year":"1995","unstructured":"Bochner BH, Cote RJ, Weidner N, Groshen S, Chen SC, Skinner DG, Nichols PW (1995) Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 87:1603\u20131612","journal-title":"J Natl Cancer Inst"},{"key":"1672_CR5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/12615","volume":"23","author":"D Cappellen","year":"1999","unstructured":"Cappellen D, De Oliveira C, Ricol D, de Medina S, Bourdin J, Sastre-Garau X, Chopin D, Thiery JP, Radvanyi F (1999) Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nat Genet 23:18\u201320","journal-title":"Nat Genet"},{"key":"1672_CR6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/labinvest.3780212","volume":"81","author":"KP Claffey","year":"2001","unstructured":"Claffey KP, Abrams K, Shih SC, Brown LF, Mullen A, Keough M (2001) Fibroblast growth factor 2 activation of stromal cell vascular endothelial growth factor expression and angiogenesis. Lab Invest J Tech Meth Pathol 81:61\u201375","journal-title":"Lab Invest J Tech Meth Pathol"},{"key":"1672_CR7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-6147(00)01676-X","volume":"22","author":"MJ Cross","year":"2001","unstructured":"Cross MJ, Claesson-Welsh L (2001) FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 22:201\u2013207","journal-title":"Trends Pharmacol Sci"},{"key":"1672_CR8","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1464-410X.1994.tb07122.x","volume":"74","author":"AJ Dickinson","year":"1994","unstructured":"Dickinson AJ, Fox SB, Persad RA, Hollyer J, Sibley GN, Harris AL (1994) Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br J Urol 74:762\u2013766","journal-title":"Br J Urol"},{"key":"1672_CR9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0002-9440(10)65254-6","volume":"154","author":"W Dietmaier","year":"1999","unstructured":"Dietmaier W, Hartmann A, Wallinger S, Heinmoller E, Kerner T, Endl E, Jauch KW, Hofstadter F, Ruschoff J (1999) Multiple mutation analyses in single tumor cells with improved whole genome amplification. Am J Pathol 154:83\u201395. doi: 10.1016\/S0002-9440(10)65254-6","journal-title":"Am J Pathol"},{"key":"1672_CR10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/scientificamerican0996-150","volume":"275","author":"J Folkman","year":"1996","unstructured":"Folkman J (1996) Fighting cancer by attacking its blood supply. Sci Am 275:150\u2013154","journal-title":"Sci Am"},{"key":"1672_CR11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1126\/science.2432664","volume":"235","author":"J Folkman","year":"1987","unstructured":"Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235:442\u2013447","journal-title":"Science"},{"key":"1672_CR12","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1016\/S0021-9258(18)53867-9","volume":"268","author":"R Forough","year":"1993","unstructured":"Forough R, Xi Z, MacPhee M, Friedman S, Engleka KA, Sayers T, Wiltrout RH, Maciag T (1993) Differential transforming abilities of non-secreted and secreted forms of human fibroblast growth factor-1. J Biol Chem 268:2960\u20132968","journal-title":"J Biol Chem"},{"key":"1672_CR13","first-page":"1063","volume":"5","author":"D Giri","year":"1999","unstructured":"Giri D, Ropiquet F, Ittmann M (1999) Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. Clin Canc Res Offic J Am Assoc Canc Res 5:1063\u20131071","journal-title":"Clin Canc Res Offic J Am Assoc Canc Res"},{"key":"1672_CR14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1158\/1078-0432.459.11.2","volume":"11","author":"JJ Gomez-Roman","year":"2005","unstructured":"Gomez-Roman JJ, Saenz P, Molina M, Cuevas Gonzalez J, Escuredo K, Santa Cruz S, Junquera C, Simon L, Martinez A, Gutierrez Banos JL, Lopez-Brea M, Esparza C, Val-Bernal JF (2005) Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth. Clin Canc Res Offic J Am Assoc Canc Res 11:459\u2013465","journal-title":"Clin Canc Res Offic J Am Assoc Canc Res"},{"key":"1672_CR15","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1172\/JCI28163","volume":"116","author":"C Hafner","year":"2006","unstructured":"Hafner C, van Oers JM, Vogt T, Landthaler M, Stoehr R, Blaszyk H, Hofstaedter F, Zwarthoff EC, Hartmann A (2006) Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J Clin Invest 116:2201\u20132207","journal-title":"J Clin Invest"},{"key":"1672_CR16","first-page":"809","volume":"62","author":"A Hartmann","year":"2002","unstructured":"Hartmann A, Schlake G, Zaak D, Hungerhuber E, Hofstetter A, Hofstaedter F, Knuechel R (2002) Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder. Cancer Res 62:809\u2013818","journal-title":"Cancer Res"},{"key":"1672_CR17","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1200\/JCO.2005.05.1771","volume":"24","author":"S Hernandez","year":"2006","unstructured":"Hernandez S, Lopez-Knowles E, Lloreta J, Kogevinas M, Amoros A, Tardon A, Carrato A, Serra C, Malats N, Real FX (2006) Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas. J Clin Oncol Offic J Am Soc Clin Oncol 24:3664\u20133671","journal-title":"J Clin Oncol Offic J Am Soc Clin Oncol"},{"key":"1672_CR18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/med.21288","volume":"34","author":"M Katoh","year":"2014","unstructured":"Katoh M, Nakagama H (2014) FGF receptors: cancer biology and therapeutics. Med Res Rev 34:280\u2013300. doi: 10.1002\/med.21288","journal-title":"Med Res Rev"},{"key":"1672_CR19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00345-007-0213-4","volume":"25","author":"MA Knowles","year":"2007","unstructured":"Knowles MA (2007) Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target. World J Urol 25:581\u2013593","journal-title":"World J Urol"},{"key":"1672_CR20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2217\/14796694.4.1.71","volume":"4","author":"MA Knowles","year":"2008","unstructured":"Knowles MA (2008) Novel therapeutic targets in bladder cancer: mutation and expression of FGF receptors. Future Oncol 4:71\u201383. doi: 10.2217\/14796694.4.1.71","journal-title":"Future Oncol"},{"key":"1672_CR21","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1054\/bjoc.2001.1809","volume":"84","author":"MA Konerding","year":"2001","unstructured":"Konerding MA, Fait E, Gaumann A (2001) 3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon. Br J Cancer 84:1354\u20131362","journal-title":"Br J Cancer"},{"key":"1672_CR22","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/j.juro.2006.07.132","volume":"176","author":"A Lamy","year":"2006","unstructured":"Lamy A, Gobet F, Laurent M, Blanchard F, Varin C, Moulin C, Andreou A, Frebourg T, Pfister C (2006) Molecular profiling of bladder tumors based on the detection of FGFR3 and TP53 mutations. J Urol 176:2686\u20132689","journal-title":"J Urol"},{"key":"1672_CR23","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1038\/sj.onc.1209249","volume":"25","author":"D Lindgren","year":"2006","unstructured":"Lindgren D, Liedberg F, Andersson A, Chebil G, Gudjonsson S, Borg A, Mansson W, Fioretos T, Hoglund M (2006) Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q. Oncogene 25:2685\u20132696","journal-title":"Oncogene"},{"key":"1672_CR24","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1158\/1078-0432.CCR-06-0206","volume":"12","author":"E Lopez-Knowles","year":"2006","unstructured":"Lopez-Knowles E, Hernandez S, Kogevinas M, Lloreta J, Amoros A, Tardon A, Carrato A, Kishore S, Serra C, Malats N, Real FX, Investigators ES (2006) The p53 pathway and outcome among patients with T1G3 bladder tumors. Clin Canc Res Offic J Am Assoc Canc Res 12:6029\u20136036","journal-title":"Clin Canc Res Offic J Am Assoc Canc Res"},{"key":"1672_CR25","first-page":"967","volume":"12","author":"M Matsumoto","year":"2004","unstructured":"Matsumoto M, Ohtsuki Y, Ochii K, Seike Y, Iseda N, Sasaki T, Okada Y, Kurabayashi A, Furihata M (2004) Fibroblast growth factor receptor 3 protein expression in urothelial carcinoma of the urinary bladder, exhibiting no association with low-grade and\/or non-invasive lesions. Oncol Rep 12:967\u2013971","journal-title":"Oncol Rep"},{"key":"1672_CR26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejso.2005.11.018","volume":"32","author":"P Mhawech-Fauceglia","year":"2006","unstructured":"Mhawech-Fauceglia P, Cheney RT, Fischer G, Beck A, Herrmann FR (2006) FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer. Eur J Surg Oncol 32:231\u2013237","journal-title":"Eur J Surg Oncol"},{"key":"1672_CR27","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1038\/sj.onc.1203066","volume":"18","author":"M Nesbit","year":"1999","unstructured":"Nesbit M, Nesbit HK, Bennett J, Andl T, Hsu MY, Dejesus E, McBrian M, Gupta AR, Eck SL, Herlyn M (1999) Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes. Oncogene 18:6469\u20136476. doi: 10.1038\/sj.onc.1203066","journal-title":"Oncogene"},{"key":"1672_CR28","doi-asserted-by":"crossref","first-page":"e48993","DOI":"10.1371\/journal.pone.0048993","volume":"7","author":"Y Neuzillet","year":"2012","unstructured":"Neuzillet Y, Paoletti X, Ouerhani S, Mongiat-Artus P, Soliman H, de The H, Sibony M, Denoux Y, Molinie V, Herault A, Lepage ML, Maille P, Renou A, Vordos D, Abbou CC, Bakkar A, Asselain B, Kourda N, El Gaaied A, Leroy K, Laplanche A, Benhamou S, Lebret T, Allory Y, Radvanyi F (2012) A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer. PLoS One 7:e48993","journal-title":"PLoS One"},{"key":"1672_CR29","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/labinvest.3700597","volume":"87","author":"MB Nourse","year":"2007","unstructured":"Nourse MB, Rolle MW, Pabon LM, Murry CE (2007) Selective control of endothelial cell proliferation with a synthetic dimerizer of FGF receptor-1. Lab Invest J Tech Meth Pathol 87:828\u2013835. doi: 10.1038\/labinvest.3700597","journal-title":"Lab Invest J Tech Meth Pathol"},{"key":"1672_CR30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cytogfr.2005.01.004","volume":"16","author":"M Presta","year":"2005","unstructured":"Presta M, Dell\u2019Era P, Mitola S, Moroni E, Ronca R, Rusnati M (2005) Fibroblast growth factor\/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16:159\u2013178. doi: 10.1016\/j.cytogfr.2005.01.004","journal-title":"Cytokine Growth Factor Rev"},{"key":"1672_CR31","first-page":"138","volume":"8","author":"W Remmele","year":"1987","unstructured":"Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138\u2013140","journal-title":"Pathologe"},{"key":"1672_CR32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/cas.12334","volume":"105","author":"T Ren","year":"2014","unstructured":"Ren T, Qing Y, Dai N, Li M, Qian C, Yang Y, Cheng Y, Li Z, Zhang S, Zhong Z, Wang D (2014) Apurinic\/apyrimidinic endonuclease 1 induced upregulation of fibroblast growth factor 2 and its receptor 3 induces angiogenesis in human osteosarcoma cells. Cancer Sci 105:186\u2013194","journal-title":"Cancer Sci"},{"key":"1672_CR33","first-page":"271","volume":"27","author":"JS Ross","year":"2014","unstructured":"Ross JS, Wang K, Al-Rohil RN, Nazeer T, Sheehan CE, Otto GA, He J, Palmer G, Yelensky R, Lipson D, Ali S, Balasubramanian S, Curran JA, Garcia L, Mahoney K, Downing SR, Hawryluk M, Miller VA, Stephens PJ (2014) Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy. Mod Pathol Offic J US Canad Acad Pathol Inc 27:271\u2013280. doi: 10.1038\/modpathol.2013.135","journal-title":"Mod Pathol Offic J US Canad Acad Pathol Inc"},{"key":"1672_CR34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1097-0215(19990219)84:1<10::AID-IJC3>3.0.CO;2-L","volume":"84","author":"NO Schmidt","year":"1999","unstructured":"Schmidt NO, Westphal M, Hagel C, Ergun S, Stavrou D, Rosen EM, Lamszus K (1999) Levels of vascular endothelial growth factor, hepatocyte growth factor\/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Canc 84:10\u201318","journal-title":"Int J Canc"},{"key":"1672_CR35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2559.1999.00657.x","volume":"35","author":"RA Soslow","year":"1999","unstructured":"Soslow RA, Nabeya Y, Ying L, Blundell M, Altorki NK (1999) Acidic fibroblast growth factor is progressively increased in the development of oesophageal glandular dysplasia and adenocarcinoma. Histopathology 35:31\u201337","journal-title":"Histopathology"},{"key":"1672_CR36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/labinvest.3700068","volume":"84","author":"R Stoehr","year":"2004","unstructured":"Stoehr R, Wissmann C, Suzuki H, Knuechel R, Krieg RC, Klopocki E, Dahl E, Wild P, Blaszyk H, Sauter G, Simon R, Schmitt R, Zaak D, Hofstaedter F, Rosenthal A, Baylin SB, Pilarsky C, Hartmann A (2004) Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer. Lab Invest J Tech Meth Pathol 84:465\u2013478. doi: 10.1038\/labinvest.3700068","journal-title":"Lab Invest J Tech Meth Pathol"},{"key":"1672_CR37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/path.2207","volume":"213","author":"DC Tomlinson","year":"2007","unstructured":"Tomlinson DC, Baldo O, Harnden P, Knowles MA (2007) FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer. J Pathol 213:91\u201398","journal-title":"J Pathol"},{"key":"1672_CR38","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1158\/0008-5472.CAN-08-2816","volume":"69","author":"DC Tomlinson","year":"2009","unstructured":"Tomlinson DC, Lamont FR, Shnyder SD, Knowles MA (2009) Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer. Cancer Res 69:4613\u20134620","journal-title":"Cancer Res"},{"key":"1672_CR39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","volume":"10","author":"N Turner","year":"2010","unstructured":"Turner N, Grose R (2010) Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 10:116\u2013129. doi: 10.1038\/nrc2780","journal-title":"Nat. Rev. Cancer"},{"key":"1672_CR40","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1158\/1078-0432.CCR-05-1045","volume":"11","author":"JM Oers van","year":"2005","unstructured":"van Oers JM, Lurkin I, van Exsel AJ, Nijsen Y, van Rhijn BW, van der Aa MN, Zwarthoff EC (2005) A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine. Clin Canc Res Offic J Am Assoc Canc Res 11:7743\u20137748. doi: 10.1158\/1078-0432.CCR-05-1045","journal-title":"Clin Canc Res Offic J Am Assoc Canc Res"},{"key":"1672_CR41","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.eururo.2007.01.009","volume":"52","author":"JM Oers van","year":"2007","unstructured":"van Oers JM, Wild PJ, Burger M, Denzinger S, Stoehr R, Rosskopf E, Hofstaedter F, Steyerberg EW, Klinkhammer-Schalke M, Zwarthoff EC, van der Kwast TH, Hartmann A (2007) FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumors. Eur Urol 52:760\u2013768. doi: 10.1016\/j.eururo.2007.01.009","journal-title":"Eur Urol"},{"key":"1672_CR42","first-page":"1265","volume":"61","author":"BW Rhijn van","year":"2001","unstructured":"van Rhijn BW, Lurkin I, Radvanyi F, Kirkels WJ, van der Kwast TH, Zwarthoff EC (2001) The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate. Cancer Res 61:1265\u20131268","journal-title":"Cancer Res"},{"key":"1672_CR43","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.juro.2011.10.172","volume":"187","author":"BW Rhijn van","year":"2012","unstructured":"van Rhijn BW, van der Kwast TH, Liu L, Fleshner NE, Bostrom PJ, Vis AN, Alkhateeb SS, Bangma CH, Jewett MA, Zwarthoff EC, Zlotta AR, Bapat B (2012) The FGFR3 mutation is related to favorable pT1 bladder cancer. J Urol 187:310\u2013314. doi: 10.1016\/j.juro.2011.09.008","journal-title":"J Urol"},{"key":"1672_CR44","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0959-8049(02)00156-9","volume":"38","author":"PB Vermeulen","year":"2002","unstructured":"Vermeulen PB, Fox SB, Dirix LY, Colpaert C, Van Marck EA (2002) Heterogeneity of vascularisation in invasive breast carcinoma. Eur J Cancer 38:1951\u20131952","journal-title":"Eur J Cancer"},{"key":"1672_CR45","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0959-8049(96)00379-6","volume":"32A","author":"PB Vermeulen","year":"1996","unstructured":"Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCulloch P, Pezzella F, Viale G, Weidner N, Harris AL, Dirix LY (1996) Quantification of angiogenesis in solid human tumors: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 32A:2474\u20132484","journal-title":"Eur J Cancer"},{"key":"1672_CR46","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/bjc.1995.68","volume":"71","author":"PB Vermeulen","year":"1995","unstructured":"Vermeulen PB, Verhoeven D, Fierens H, Hubens G, Goovaerts G, Van Marck E, De Bruijn EA, Van Oosterom AT, Dirix LY (1995) Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study. Br J Cancer 71:340\u2013343","journal-title":"Br J Cancer"},{"key":"1672_CR47","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/(SICI)1096-9896(199911)189:3<297::AID-PATH434>3.0.CO;2-O","volume":"189","author":"N Weidner","year":"1999","unstructured":"Weidner N (1999) Tumor vascularity and proliferation: clear evidence of a close relationship. J Pathol 189:297\u2013299. doi: 10.1002\/(SICI)1096-9896(199911)189:3<297::AID-PATH434>3.0.CO;2-O","journal-title":"J Pathol"},{"key":"1672_CR48","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/hmg\/dds486","volume":"22","author":"SV Williams","year":"2013","unstructured":"Williams SV, Hurst CD, Knowles MA (2013) Oncogenic FGFR3 gene fusions in bladder cancer. Hum Mol Genet 22:795\u2013803. doi: 10.1093\/hmg\/dds486","journal-title":"Hum Mol Genet"},{"key":"1672_CR49","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1158\/1078-0432.CCR-05-1130","volume":"11","author":"K Zieger","year":"2005","unstructured":"Zieger K, Dyrskjot L, Wiuf C, Jensen JL, Andersen CL, Jensen KM, Orntoft TF (2005) Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors. Clin Canc Res Offic J Am Assoc Canc Res 11:7709\u20137719. doi: 10.1158\/1078-0432.CCR-05-1130","journal-title":"Clin Canc Res Offic J Am Assoc Canc Res"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-014-1672-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-014-1672-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-014-1672-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T06:32:27Z","timestamp":1689575547000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-014-1672-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,19]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1672"],"URL":"https:\/\/doi.org\/10.1007\/s00428-014-1672-9","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,19]]}}}